Correction to: Prognostic role of EGFR gene copy number and KRAS mutation in patients with locally advanced rectal cancer treated with preoperative chemoradiotherapy.
作者信息
Bengala C, Bettelli S, Bertolini F, Sartori G, Fontana A, Malavasi N, Depenni R, Zironi S, Del Giovane C, Luppi G, Conte P F
机构信息
Division of Medical Oncology, Department of Oncology, Hematology and Respiratory Disease, University Hospital, University of Modena and Reggio Emilia, Via del Pozzo, 71, Modena, 41100, Italy.
Institute of Pathology and Cell Biology, Department of Laboratories, Pathology and Forensic Medicine, University Hospital, University of Modena and Reggio Emilia, Via del Pozzo, 71, Modena, 41100, Italy.
出版信息
Br J Cancer. 2024 Sep;131(5):954. doi: 10.1038/s41416-024-02790-9.
Abstract
摘要
相似文献
1
Correction to: Prognostic role of EGFR gene copy number and KRAS mutation in patients with locally advanced rectal cancer treated with preoperative chemoradiotherapy.对《表皮生长因子受体基因拷贝数和KRAS突变在接受术前放化疗的局部晚期直肠癌患者中的预后作用》的更正
Br J Cancer. 2024 Sep;131(5):954. doi: 10.1038/s41416-024-02790-9.
2
Prognostic role of EGFR gene copy number and KRAS mutation in patients with locally advanced rectal cancer treated with preoperative chemoradiotherapy.术前放化疗治疗局部进展期直肠癌患者中 EGFR 基因拷贝数和 KRAS 突变的预后作用。
Br J Cancer. 2010 Sep 28;103(7):1019-24. doi: 10.1038/sj.bjc.6605853. Epub 2010 Sep 14.
3
KRAS mutation status and clinical outcome of preoperative chemoradiation with cetuximab in locally advanced rectal cancer: a pooled analysis of 2 phase II trials.KRAS 突变状态和西妥昔单抗术前放化疗治疗局部晚期直肠癌的临床结局：2 项 II 期试验的汇总分析。
Int J Radiat Oncol Biol Phys. 2013 Jan 1;85(1):201-7. doi: 10.1016/j.ijrobp.2012.03.048. Epub 2012 Jun 5.
4
Oncogene mutation profile predicts tumor regression and survival in locally advanced rectal cancer patients treated with preoperative chemoradiotherapy and radical surgery.癌基因突变谱可预测接受术前放化疗及根治性手术的局部晚期直肠癌患者的肿瘤退缩及生存情况。
Tumour Biol. 2017 Jul;39(7):1010428317709638. doi: 10.1177/1010428317709638.
5
KRAS and BRAF mutations in patients with rectal cancer treated with preoperative chemoradiotherapy.术前放化疗治疗的直肠癌患者的 KRAS 和 BRAF 突变。
Radiother Oncol. 2010 Jan;94(1):76-81. doi: 10.1016/j.radonc.2009.10.001. Epub 2009 Nov 11.
6
Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: Outcomes of survival, toxicity, sphincter preserving and prognostic factors.局部进展期直肠癌术前与术后放化疗的比较：生存、毒性、保肛和预后因素的结果。
Transpl Immunol. 2021 Dec;69:101489. doi: 10.1016/j.trim.2021.101489. Epub 2021 Oct 20.
7
Genome landscapes of rectal cancer before and after preoperative chemoradiotherapy.直肠癌术前放化疗前后的基因组图谱。
Theranostics. 2019 Sep 21;9(23):6856-6866. doi: 10.7150/thno.37794. eCollection 2019.
8
The impact of clinical outcomes according to EGFR mutation status in patients with locally advanced lung adenocarcinoma who recieved concurrent chemoradiotherapy.接受同步放化疗的局部晚期肺腺癌患者中，根据表皮生长因子受体（EGFR）突变状态对临床结局的影响。
Am J Clin Oncol. 2014 Apr;37(2):144-7. doi: 10.1097/COC.0b013e31826e04f9.
9
10
Prognostic and Predictive Biomarkers in Patients with Locally Advanced Rectal Cancer (LARC) Treated with Preoperative Chemoradiotherapy.术前放化疗治疗的局部晚期直肠癌（LARC）患者的预后和预测生物标志物
J Clin Med. 2022 Oct 16;11(20):6091. doi: 10.3390/jcm11206091.
引用本文的文献
1
Prognosis and influencing factors of patients with different lymph node statuses after pathological complete response to neoadjuvant chemoradiotherapy in rectal cancer.直肠癌新辅助放化疗后病理完全缓解的不同淋巴结状态患者的预后及影响因素
Oncol Lett. 2025 May 22;30(1):359. doi: 10.3892/ol.2025.15105. eCollection 2025 Jul.
Zotero 插件